Debruyne PR - Search Results

1

Pseudoprogression and Mixed Responses in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab: A Retrospective Analysis.

Haaker L, Baldewijns M, De Wever L, Albersen M, Debruyne PR, Wynendaele W, De Meerleer G, Beuselinck B. Haaker L, et al. Among authors: debruyne pr. Clin Genitourin Cancer. 2023 Aug;21(4):442-451. doi: 10.1016/j.clgc.2023.03.003. Epub 2023 Mar 9. Clin Genitourin Cancer. 2023. PMID: 36997468

2

Bile acids initiate lineage-addicted gastroesophageal tumorigenesis by suppressing the EGF receptor-AKT axis.

Gong L, Debruyne PR, Witek M, Nielsen K, Snook A, Lin JE, Bombonati A, Palazzo J, Schulz S, Waldman SA. Gong L, et al. Among authors: debruyne pr. Clin Transl Sci. 2009 Aug;2(4):286-93. doi: 10.1111/j.1752-8062.2009.00131.x. Clin Transl Sci. 2009. PMID: 20443907 Free PMC article.

3

Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathways.

Debruyne PR, Bruyneel EA, Karaguni IM, Li X, Flatau G, Müller O, Zimber A, Gespach C, Mareel MM. Debruyne PR, et al. Oncogene. 2002 Oct 3;21(44):6740-50. doi: 10.1038/sj.onc.1205729. Oncogene. 2002. PMID: 12360401

4

A call for rigorous research and transparent study reporting ….

Debruyne PR, Knott VE, Pattison NA. Debruyne PR, et al. Eur J Cancer Care (Engl). 2013 Jul;22(4):421-2. doi: 10.1111/ecc.12086. Eur J Cancer Care (Engl). 2013. PMID: 23773162 No abstract available.

5

[(Added) Value of a clinical pharmacist in the oncology department and optimalisation of the applicability of geriatric tools assessing potential inappropriate medication use in geriatric patients (Drug Burden Index and de Beers criteria)].

Van Den Broucke J, Verhaeghe A, Debruyne PR, Verhelle K. Van Den Broucke J, et al. Among authors: debruyne pr. J Pharm Belg. 2014 Mar;(1):28-36. J Pharm Belg. 2014. PMID: 24804391 Review. French.

6

Single alteration of p53 or E-cadherin genes can alter the surgical resection benefit in an experimental model of colon cancer.

Pocard M, Debruyne P, Bras-Gonçalves R, Mareel M, Dutrillaux B, Poupon MF. Pocard M, et al. Dis Colon Rectum. 2001 Aug;44(8):1106-12. doi: 10.1007/BF02234630. Dis Colon Rectum. 2001. PMID: 11535849

7

Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases.

Beuselinck B, Wolter P, Karadimou A, Elaidi R, Dumez H, Rogiers A, Van Cann T, Willems L, Body JJ, Berkers J, Van Poppel H, Lerut E, Debruyne P, Paridaens R, Schöffski P. Beuselinck B, et al. Br J Cancer. 2012 Nov 6;107(10):1665-71. doi: 10.1038/bjc.2012.385. Br J Cancer. 2012. PMID: 23132391 Free PMC article.

8

Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinib.

Beuselinck B, Vano YA, Oudard S, Wolter P, De Smet R, Depoorter L, Teghom C, Karadimou A, Zucman-Rossi J, Debruyne PR, Van Poppel H, Joniau S, Lerut E, Strijbos M, Dumez H, Paridaens R, Van Calster B, Schöffski P. Beuselinck B, et al. Among authors: debruyne pr. BJU Int. 2014 Jul;114(1):81-9. doi: 10.1111/bju.12494. Epub 2014 Jan 15. BJU Int. 2014. PMID: 24215209

9

Outcomes from second-line therapy in long-term responders to first-line tyrosine kinase inhibitor in clear-cell metastatic renal cell carcinoma.

Elaidi R, Harbaoui A, Beuselinck B, Eymard JC, Bamias A, De Guillebon E, Porta C, Vano Y, Linassier C, Debruyne PR, Gross-Goupil M, Ravaud A, Aitelhaj M, Marret G, Oudard S. Elaidi R, et al. Among authors: debruyne pr. Ann Oncol. 2015 Feb;26(2):378-85. doi: 10.1093/annonc/mdu552. Epub 2014 Dec 1. Ann Oncol. 2015. PMID: 25467013 Free article.

10

Prognostic factors in second-line targeted therapy for metastatic clear-cell renal cell carcinoma after progression on an anti-vascular endothelial growth factor receptor tyrosine kinase inhibitor.

Sacré A, Barthélémy P, Korenbaum C, Burgy M, Wolter P, Dumez H, Lerut E, Loyson T, Joniau S, Oyen R, Debruyne PR, Schöffski P, Beuselinck B. Sacré A, et al. Among authors: debruyne pr. Acta Oncol. 2016;55(3):329-40. doi: 10.3109/0284186X.2015.1099731. Epub 2015 Oct 23. Acta Oncol. 2016. PMID: 26494607

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

79 results

Search Page